期刊文献+

胎儿生长受限病因研究新进展 被引量:3

下载PDF
导出
出处 《右江医学》 2007年第4期450-452,共3页 Chinese Youjiang Medical Journal
  • 相关文献

参考文献25

  • 1赵峻,吴连方.胎儿生长受限病因研究进展[J].中华围产医学杂志,2003,6(3):187-189. 被引量:18
  • 2Das UG,Sadip HF,Soares MJ,et al.Time-dependent Physiological regulation of rodent and ovine placental glucose transporter (GLUT-Ⅰ) protein[J].Am J Physiol,1998,274(2 Pt2):R339 -347.
  • 3Aubard Y,Darodes N,Cantaloube M.Hyperhomocysteinemia and pregnancy-review of our present understanding and therapeutic implications[J].Eur J Obstet Cynecol Reprod,2000,93(2):155-157.
  • 4董彦亮.胎儿宫内发育迟缓的病因[J].中国实用妇科与产科杂志,2002,18(1):6-8. 被引量:26
  • 5Carro E,Senaris R,Considine RV,et al.Regulation of in vivo growth secretion by leptin[J].Endocrinology,1997,138(5):2203-2205.
  • 6Mise H,Sagawa N,Matsumoto T,et al.Augmented placental production of leptin in preeclampsia:possible involvement of placental hypoxia[J].J Clin Endocrinol Metab,1998,83 (9):3225 -3228.
  • 7刘虹,梁雪雯,王彦德.瘦素及胰岛素样生长因子-Ⅰ与胎儿生长受限的关系[J].中国实用妇科与产科杂志,2004,20(6):361-362. 被引量:19
  • 8Tamura T,Coldenberg RL,Johnston KE,el al.Serum leptin concentrations during oregnancy and their relationship with fetal growth[J].Obstet Gynecol,1998,91(3):389-392.
  • 9Arosio M,Cortetazzi O,Perani L,et al.Circulation Levels of growth hormone,insulin-like growth factor-1 and prolactin in normal,growth retarded,and anencephalic human fetuses[J].J Endocrinol Invest,1995,18(2):346-350.
  • 10王兆平,范燕燕,吴桂芳,黄曙光,程宁,唐敏红,孙达成,周萍芳.胎儿生长迟缓与抗心磷脂抗体的相关性[J].中华妇产科杂志,1997,32(10):623-625. 被引量:9

二级参考文献47

共引文献274

同被引文献24

  • 1韩小英,于荣,刘维靖.胎儿宫内生长受限相关临床因素的分析[J].首都医科大学学报,2005,26(3):348-350. 被引量:14
  • 2张红花.丹参、黄芪、麦冬治疗胎儿生长受限疗效探讨[J].实用中西医结合临床,2006,6(4):9-10. 被引量:4
  • 3兰素华,解葆冬,李立功,陈秀春.中西医结合治疗胎儿生长受限104例疗效观察[J].光明中医,2007,22(8):78-78. 被引量:3
  • 4Divon MY, Hsu HW. Maternal and feral blood flow velocity waveforms in intrauterine growth retardation[J]. Clin Obstet Gynecol, 1992,35(2) :156-171.
  • 5Komiyama Y, Nakae S, Matsuki T, et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis[J]. J Immunol, 2006, 177 (1) :566-573.
  • 6Kolls JK, Linden A. Interleukin-17 family members and inflammation[J]. Immunity, 2004, 21(4) :467-476.
  • 7Yoshida S, Haque A, Mizobuehi T, et al. Anti-type V collagen lymphocytes that express IL-17 and IL 23 induce rejection pathology in fresh and well-healed lung transplants [J]. Am J Transplant, 2006,6(4): 724-735.
  • 8Maini RN, Taylor PC, Szeehinski J, et al. Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate[J]. Arthritis Rheum, 2006,54(9) :2817-2829.
  • 9Matusevicius D, Kivisakk P, He B, et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis[J]. Mult Scler, 1999,5(2) : 101-104.
  • 10Wong CK, Ho CY, Li EK, et al. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus[J]. Lupus, 2000,9(8): 589-593.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部